HighVista Strategies LLC
Top Portfolio Positions
154 positions ·
$359,474,418 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| DBC |
Invesco DB Commodity Index Tracking Fund
|
1,057,238 | $30,607,040 | 8.51% | |
| ABVX |
Abivax S.A.
Healthcare
|
113,254 | $12,610,832 | 3.51% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
26,323 | $8,481,007 | 2.36% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
197,051 | $7,584,492 | 2.11% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
146,264 | $7,377,556 | 2.05% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
124,647 | $7,243,237 | 2.01% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
69,309 | $6,740,300 | 1.88% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
114,307 | $6,026,265 | 1.68% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
123,909 | $5,972,413 | 1.66% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
56,602 | $5,798,874 | 1.61% |
Portfolio Trend
Holdings in SYRE
Shares Held
Position Value (USD)
10 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,377,556 | 146,264 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,165,628 | 188,206 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,615,902 | 215,746 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,688,690 | 112,805 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,535,390 | 95,159 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,215,301 | 95,159 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,098,372 | 105,351 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,669,560 | 113,550 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,855,671 | 154,381 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $12,430,296 | 577,616 | Shares | Sole | 2024-02-14 | |
| No 13F history on record for this holder in this stock. | ||||||